×
For best experience we recommend to activate Javascript in your browser.
AKR7A2 antibody (N-Term)
This anti-AKR7A2 antibody is a Rabbit Polyclonal antibody detecting AKR7A2 in WB. Suitable for Human and Mouse.
Quick Overview for AKR7A2 antibody (N-Term) (ABIN391275)
Target
See all AKR7A2 Antibodies
AKR7A2
(Aflatoxin Beta1 Aldehyde Reductase (AKR7A2))
Reactivity
All reactivities for AKR7A2 antibodies
Human, Mouse
Host
All hosts for AKR7A2 antibodies
Rabbit
Clonality
All clonalities for AKR7A2 antibodies
Polyclonal
Conjugate
All conjugates for AKR7A2 antibodies
This AKR7A2 antibody is un-conjugated
Application
All applications for AKR7A2 antibodies
Western Blotting (WB)
Clone
RB17972
Product Details anti-AKR7A2 Antibody
(hide)
Binding Specificity
All epitopes for AKR7A2 antibodies
AA 101-129, N-Term
Predicted Reactivity
Rat
Purification
This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Immunogen
This AKR7A2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 101-129 amino acids from the N-terminal region of human AKR7A2.
Isotype
Ig Fraction
Alternatives
(show)
Application Details
(hide)
Application Notes
WB: 1:1000
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Expiry Date
6 months
Target Details for AKR7A2
(hide)
Target
AKR7A2
(Aflatoxin Beta1 Aldehyde Reductase (AKR7A2))
Alternative Name
AKR7A2
Background
AKR7A2 is aldo-keto reductases, which are involved in the detoxification of aldehydes and ketones.
Molecular Weight
39589
Gene ID
8574
NCBI Accession
NP_003680
UniProt
O43488
Recently viewed
(hide)
Chat with us , powered by LiveChat